These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38770341)

  • 1. Increasing the planting density of
    Amissah JN; Opoku-Agyemang F; Asem FE; Osei-Safo D; Addae-Mensah I
    Heliyon; 2024 May; 10(10):e30932. PubMed ID: 38770341
    [No Abstract]   [Full Text] [Related]  

  • 2. Mineral Fertilization Influences the Growth, Cryptolepine Yield, and Bioefficacy of
    Amissah JN; Alorvor FE; Okorley BA; Asare CM; Osei-Safo D; Appiah-Opong R; Addae-Mensah I
    Plants (Basel); 2022 Jan; 11(1):. PubMed ID: 35009125
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro anti-malarial interaction and gametocytocidal activity of cryptolepine.
    Forkuo AD; Ansah C; Mensah KB; Annan K; Gyan B; Theron A; Mancama D; Wright CW
    Malar J; 2017 Dec; 16(1):496. PubMed ID: 29282057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptolepis sanguinolenta activity against diarrhoeal bacteria.
    Paulo A; Pimentel M; Viegas S; Pires I; Duarte A; Cabrita J; Gomes ET
    J Ethnopharmacol; 1994 Oct; 44(2):73-7. PubMed ID: 7853867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptolepis sanguinolenta: antimuscarinic properties of cryptolepine and the alkaloid fraction at M1, M2 and M3 receptors.
    Rauwald HW; Kober M; Mutschler E; Lambrecht G
    Planta Med; 1992 Dec; 58(6):486-8. PubMed ID: 1484884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptolepine hydrochloride: a potent antimycobacterial alkaloid derived from Cryptolepis sanguinolenta.
    Gibbons S; Fallah F; Wright CW
    Phytother Res; 2003 Apr; 17(4):434-6. PubMed ID: 12722159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the anticancer potential of the antimalarial herbal cryptolepis sanguinolenta and its major alkaloid cryptolepine.
    Ansah C; Mensah KB
    Ghana Med J; 2013 Sep; 47(3):137-47. PubMed ID: 24391229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in the Chemistry and Pharmacology of Cryptolepine.
    Shnyder SD; Wright CW
    Prog Chem Org Nat Prod; 2021; 115():177-203. PubMed ID: 33797643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptolepine, the Main Alkaloid of the Antimalarial
    Mensah KB; Benneh C; Forkuo AD; Ansah C
    Biochem Res Int; 2019; 2019():7076986. PubMed ID: 31360547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in naturally derived antimalarials: cryptolepine analogues.
    Wright CW
    J Pharm Pharmacol; 2007 Jun; 59(6):899-904. PubMed ID: 17637183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ethanolic extract of Cryptolepis sanguinolenta stem on in vivo and in vitro glucose absorption and transport: Mechanism of its antidiabetic activity.
    Ajayi AF; Akhigbe RE; Adewumi OM; Okeleji LO; Mujaidu KB; Olaleye SB
    Indian J Endocrinol Metab; 2012 Mar; 16 Suppl 1(Suppl1):S91-6. PubMed ID: 22701855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unravelling the pharmacological properties of cryptolepine and its derivatives: a mini-review insight.
    Tudu CK; Bandyopadhyay A; Kumar M; Radha ; Das T; Nandy S; Ghorai M; Gopalakrishnan AV; Proćków J; Dey A
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Feb; 396(2):229-238. PubMed ID: 36251044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibacterial screening of Cryptolepis sanguinolenta alkaloids.
    Paulo A; Duarte A; Gomes ET
    J Ethnopharmacol; 1994 Oct; 44(2):127-30. PubMed ID: 7853864
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Amponsah IK; Atchoglo PK; Ackah RY; Tsouh Fokou PV; Aboagye SY; Yeboah-Manu D; Appiah-Opong R; Mensah AY
    Int J Mycobacteriol; 2021; 10(1):60-65. PubMed ID: 33707373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro genotoxicity of the West African anti-malarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine.
    Ansah C; Khan A; Gooderham NJ
    Toxicology; 2005 Mar; 208(1):141-7. PubMed ID: 15664441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo antiplasmodial activity of cryptolepine and related alkaloids from Cryptolepis sanguinolenta.
    Cimanga K; De Bruyne T; Pieters L; Vlietinck AJ; Turger CA
    J Nat Prod; 1997 Jul; 60(7):688-91. PubMed ID: 9249972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activities.
    Bierer DE; Fort DM; Mendez CD; Luo J; Imbach PA; Dubenko LG; Jolad SD; Gerber RE; Litvak J; Lu Q; Zhang P; Reed MJ; Waldeck N; Bruening RC; Noamesi BK; Hector RF; Carlson TJ; King SR
    J Med Chem; 1998 Mar; 41(6):894-901. PubMed ID: 9526563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial, antioxidant activities, and total phenolic contents of Pycnanthus angolensis Sap and Cryptolepis sanguinolenta root extracts.
    Adu-Amankwaah F; Sam H; Asare CY; Mills-Robertson FC
    BMC Complement Med Ther; 2023 Jun; 23(1):205. PubMed ID: 37344802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constituents of West African medicinal plants XX: quindoline from Cryptolepis sanguinolenta.
    Dwuma-Badu D; Ayim JS; Fiagbe NI; Knapp JE; Schiff PL; Slatkin DJ
    J Pharm Sci; 1978 Mar; 67(3):433-4. PubMed ID: 641744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptolepine inhibits hepatocellular carcinoma growth through inhibiting interleukin-6/STAT3 signalling.
    Domfeh SA; Narkwa PW; Quaye O; Kusi KA; Awandare GA; Ansah C; Salam A; Mutocheluh M
    BMC Complement Med Ther; 2021 Jun; 21(1):161. PubMed ID: 34078370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.